Celldex Therapeutics | CLDX - Efectivo Y Equivalentes





Efectivo Y Equivalentes Cambio Fecha
AbbVie USD 6.57B 2.82B 2026-06
Agenus USD 18.74M 16.26M 2026-06
Amgen USD 13.99B 1.95B 2026-06
Bristol-Myers Squibb USD 8.72B 852M 2026-06
Celldex Therapeutics USD 47.45M 11.72M 2026-06
Glaxosmithkline GBP 3.44B 146M 2026-03
Nektar Therapeutics USD 149.58M 134.46M 2026-03
Northwest Biotherapeutics USD 4.56M 244K 2025-09
Pfizer USD 976M 727M 2026-06
Rigel Pharmaceuticals USD 48.53M 4.87M 2025-09
Roche Holding CHF 7.55B 579M 2025-06